by Brittany Scaturro | Nov 6, 2015 | Posters | 0 comments
CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD)
BARCELONA, SPAIN, NOVEMBER 5-7, 2015
The TOMMORROW Study is an international trial using MCI-AD as the primary endpoint. In preparation for initiating the TOMMORROW Study in German-speaking countries, we conducted a validation and normative study of the TOMMORROW neurocognitive battery in Basel, Switzerland.
Our website uses cookies to personalize content, save your preferences, and enhance your overall experience. If you click accept or continue to navigate our website, you agree to having those cookies set on your device. To learn more about adjusting your preferences please visit our WCG Privacy Policy. Accept Reject
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Undefined cookies are those that are being analyzed and have not been classified into a category as yet.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.